Zenas BioPharma, Inc. (ZBIO) › Cash & EquivalentsZenas BioPharma, Inc. (ZBIO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $56.86M2024: $319.74M2025: $110.64M$110.64M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$110.64M-65.4%2024$319.74M+462.4%2023$56.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share